The White House on Tuesday responded to concerns voiced by a Moderna executive who suggested the current vaccines slotted to fight the coronavirus will not be enough to counter the new omicron ...

Moderna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a modified version will be needed to boost protection against the new variant later this year.

COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot. The new ...

Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world. The germ didn’t ...

Moderna has begun testing an Omicron-specific COVID-19 booster in healthy adults. The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor ...

Opinions expressed by Forbes Contributors are their own. Dave Wessner is a virologist who covers infectious diseases. In the continuing effort to mitigate the effects of Covid-19, the U.S. Food ...

The government plans to roll out new vaccines specifically designed to protect people from the Omicron variant with booster shots starting as early as September, sources said. The inoculation ...